*Huge 30% growth YoY*

KSCL:Q1 Result today

DoW estimates Q1 NP at _203 Cr Vs 154 Cr_. KSCL likely to best all Street estimates including CNBC by big margin

Further KSCL has introduced highly profitable Micronutrients which can add 30cr to its bottom line from FY19

*FY18 NP is estimated at 240-260 Cr Vs 87cr in FY17*

Stock price can be 775 August expiry